Clinical Trial Update: MiSaver® Stem Cell Treatment for Acute Myocardial Infarction

View source ↗

Summary

The trial evaluating MiSaver Stem Cell Treatment for Acute Myocardial Infarction has completed. No efficacy results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MiSaver (Stem cell treatment)

Snippet

Sponsor: Honya Medical Inc | Conditions: Acute Myocardial Infarction | Status: COMPLETED